Three strikes and you’re out? Not for Supernus Pharmaceuticals and its Parkinson’s disease infusion pump. On its fourth attempt to pass muster with the FDA, the company’s SPN-830 ...

Opens in a new tab or window The FDA approved an apomorphine hydrochloride infusion device (Onapgo ... and the resulting pulsatile stimulation of dopamine pathways in the brain," said Stuart ...

Americans will soon have access to an infusion device that provides round ... and the resulting pulsatile stimulation of dopamine pathways in the brain," said Dr Stuart Isaacson, Director of ...

In this conference, it was emphasised that a high percentage of sentinel/drug-adverse events are due to pump use errors and that it is necessary to improve the safety features of the design and define ...

BD (NYSE: BDX) + plans to close a facility in Caesarea, Israel, by the middle of the year. BD continuously reviews its global manufacturing and supply chain network to optimize operations and ...